Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 8Breast 3Gastrointestinal 2Thoracic 1Sarcoma 1Gynecologic 1CNS 1

Conditions

Ovarian Neoplasms 14Uterine Cervical Neoplasms 10Fallopian Tube Neoplasms 9Carcinoma, Ovarian Epithelial 7Peritoneal Neoplasms 4Neoplasm, Residual 2Stomach Neoplasms 1Stage III and IV Ovarian Cancer 1Sarcoma 1Recurrence 1Postoperative Complications 1Neoplasms 1Locally Advanced Cervical Cancer 1Intermittent Fasting 1Endometrial Neoplasms 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Carcinoma 1Advanced Ovarian Cancer 1

Interventions

Paclitaxel 28Carboplatin 28pembrolizumab 25Bevacizumab 14liposomal doxorubicin 12Cisplatin 11Gemcitabine 10Radiotherapy 8Drug Therapy 8Cyclophosphamide 8Blood Specimen Collection 8Topotecan 7Nivolumab 7olaparib 6Doxorubicin 6niraparib 5Therapeutics 5Dexamethasone 5pertuzumab 4pazopanib 4lenvatinib 4fludarabine 4cemiplimab 4atezolizumab 4Trastuzumab 4Surveys and Questionnaires 4Psychiatric Rehabilitation 4Polymerase Chain Reaction 4Fulvestrant 4Docetaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Neoadjuvant Therapy × Gynecologic × Clear all
NCT05384366 2022-05-20

Neoadjuvant Chemotherapy in Cervical Cancer

Banaras Hindu University

Phase 3 Completed
33 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡